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Tegumentary leishmaniasis is an endemic protozoan disease that, in Brazil, is caused by parasites from
Viannia or Leishmania complex. The clinical forms of cutaneous disease comprise localized, disseminated,
mucosal or mucocutaneous, and diffuse leishmaniasis. Viannia complex parasites are not easy to isolate
from patient lesions, especially from mucosal lesions, and they are difﬁcult to culture. The aim of the
present study was to compare the efﬁciency of ex vivo (culture) and in vivo (IFNc-deﬁcient mice) parasite
isolation methods to improve the isolation rate and storage of stocks of New World Leishmania sp that
cause cutaneous leishmaniasis (CL) or mucosal leishmaniasis (ML). Biopsy fragments from cutaneous
or mucosal lesions were inoculated into culture medium or mouse footpads. We evaluated 114 samples
(86 CL, 28 ML) using both methods independently. Samples from CL patients had a higher isolation rate in
ex vivo cultures than in mice (34.1% vs. 18.7%, P < 0.05). Nevertheless, almost twice the number of isolates
from ML lesions was isolated using the mouse model compared to ex vivo cultures (mouse, 6/25; culture,
3/27). The overall rates of isolation were 40.2% for CL samples and 29.6% for ML samples. Of the 43 iso-
lations, we successfully stocked 35 isolates (81.4%; 27 CL, 8 ML). Contaminations were more frequently
detected in cultures of ML than CL lesions. For comparison, the use of both methods simultaneously was
performed in 74 samples of CL and 25 samples of ML, and similar results were obtained. Of the eight ML
isolates, ﬁve were isolated only in mice, indicating the advantage of using the in vivomethod to obtain ML
parasites. All parasites obtained from in vivo isolation were cryopreserved, whereas only 68% of ex vivosevier OA license. 
a), mapoliv@usp.br, karoline.af@gmail.com (A.K.A. Flueri), fernanda.bugalho@gmail.com (F.B. Duarte), sebastiaoap@
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M.L. Dorta et al. / Experimental Parasitology 132 (2012) 300–303 301isolations from CL lesions were stocked. In conclusion, the use of genetically modiﬁed mice can improve
the isolation of parasites from ML. Isolation and stocking of New World Leishmania parasites, especially
those from ML that are almost absent in laboratory stocks, are critical for evaluating parasite genetic
diversity as well as studying host–parasite interactions to identify biological markers of Leishmania. In
this paper, we also discuss some of the difﬁculties associated with isolating and stocking parasites.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
American tegumentary leishmaniasis (ATL) is an endemic proto-
zoan disease with an incidence of approximately 28,000 cases per
year in Brazil. In Brazil, ATL is caused by Leishmania sp of the Viannia
or Leishmania complex. The most prevalent species are Leishmania
(V.) braziliensis and Leishmania (Leishmania) amazonensis (Cupolillo
et al., 2003; Guerra et al., 2011; Lindoso and Lindoso, 2009). The
clinical forms of ATL caused by these species comprise localized
cutaneous leishmaniasis (LCL, usually one lesion), disseminated
cutaneous leishmaniasis (DCL), mucosal (ML) or mucocutaneous
leishmaniasis (MCL, affecting the nasal and oropharynx mucosa),
and diffuse cutaneous leishmaniasis (DfCL, several lesions, patients
do not present cellular immune response to the parasite, usually
Leishmania (Leishmania) amazonensis) (Reithinger et al., 2007; Pere-
ira et al., 2009; Silveira et al., 2009). Viannia complex parasites are
not easy to isolate from patient lesions and are difﬁcult to culture,
especially fromML lesions that normally contain very low numbers
of parasites (Shaw and Lainson, 1981; Lemesre et al., 1988; Lainson
et al., 1994). We previously proposed using C57BL/6 mice with dis-
rupted interferon gamma (IFNc) gene (IFNc KO mice) to isolate
New World Leishmania (Oliveira et al., 2010), based on the pivotal
function of this cytokine in the protective immune response against
Leishmania (Reithinger et al., 2007). At that time, we had evaluated
25 cases of ATL, including only three cases ofML, and suggested that
the use of IFNc KO mice could improve the isolation of New World
Leishmania (Oliveira et al., 2010). We have expanded the previous
study and now report the improved efﬁciency of IFNc KOmice over
ex vivo cultures for the isolation of New World Leishmania from
mucosal lesion fragments. The difﬁculties associated with isolating
and maintaining stocks of the parasites are also discussed.2. Material and methods
2.1. Patients and animals
Patients were assisted at Anuar Auad Hospital, a reference hos-
pital for ATL treatment in Goiás, a state of west central region of
Brazil that treats patients from the northern, northeastern and
western central regions of Brazil. Between the years 2006 and
2010, biopsy fragments from cutaneous and mucosal lesions were
collected for parasite isolation as part of the exams to diagnose
ATL. Biopsies were considered positive when parasites were ob-
served in any culture, mouse, histopathological or immunohisto-
chemistry assay. Female or male IFNc KO C57BL/6 mice were
bred and maintained at the animal facilities of the Tropical Pathol-
ogy and Public Health Institute, Federal University of Goiás. The
mice were purchased from Jackson Laboratories, ME, USA
(B6.129S7–ifngtm1Ts), and were maintained in a mouse facility with
ad libitum access to water and food. The Ethical Committee of the
Hospital das Clínicas of the Federal University of Goiás approved
all of the procedures reported here.
2.2. Parasites and molecular characterization
The parasites were isolated as described by Oliveira et al.
(2010). Brieﬂy, part of the lesion fragment was macerated inphosphate-buffered saline, pH 7.3, and inoculated into the dermis
of the footpad of six to 12-week-old IFNc KO mice (in vivo isola-
tion) or into 24-well culture plates containing Grace’s insect med-
ium (Sigma Chemical Co., St. Louis, MO, USA) supplemented with
20% heat-inactivated fetal calf serum (FCS, Cripion, Andradina,
São Paulo, Brazil), 2 mM L-glutamine, 100 U/ml penicillin, and
100 lg/ml streptomycin (Grace’s medium; ex vivo isolation). After
footpad lesions reached a size of approximately 2–3 mm, they
were collected, macerated, and cultured in Grace’s medium at
26 C. A portion of the macerate was injected into the footpad of
another mouse to prevent the loss of the isolated parasite by fur-
ther culture contamination. Parasites were cryopreserved directly
from cultures of patient fragment biopsies or mouse fragment le-
sions when there was a high density of parasites (>107 parasites/
mL). Additionally, after starting subcultures with approximately
1  106 parasites/ml, and allowing them to grow for two to three
days, parasites (107/ml) in the log phase of growth were cryopre-
served. Parasites were frozen in liquid nitrogen in FCS containing
10% dimethyl sulfoxide and stored as part of our bank of parasites
(Leishbank). Cultures were maintained for one month and mice for
10 months before being discarded.
The subgenus of Leishmaniawas characterized using a polymer-
ase chain reaction (PCR) (Passos et al., 1996; Volpini et al., 2004) in
57% of the samples (65/114 biopsies and isolates).3. Results
Initially, we evaluated 114 conﬁrmed ATL samples (86 from CL
and 28 from ML) using ex vivo and in vivo isolation methods inde-
pendently. In Table 1, we show the overall rates of parasite detec-
tion in cultures and in mice. The overall rate of parasite isolation
was 28.6% in cultures and 20.0% in mice, with a total of 37.8% of
the samples yielding parasites (43 isolations/114 samples, Table
1). Samples from CL patients had a higher isolation rate in
ex vivo cultures than in mice (34.1% vs. 18.7%, P < 0.05, Fisher’s test,
Table 1). On the other hand, we obtained almost twice the number
of isolates from ML lesions using the mouse model compared to
the ex vivo cultures (mouse, 6/25; culture, 3/27; Table 1). When
both methods were used together, we observed overall rates of iso-
lation of 40.2% for CL samples and 29.6% for ML samples. Of the 43
isolations, we successfully preserved 35 isolates in our Leishbank
(81.4%). The successfully stocked isolates included 77.1% of the
CL parasites (27/35, Table 1) and 100% of the ML parasites (8/8, Ta-
ble 1). Contamination during culture of the patient biopsy frag-
ments was more frequently detected in samples from ML than CL
patients (29.6% vs. 17.6%, Table 1) and was caused mainly by yeast.
Subgenus characterization of the parasites identiﬁed 93.8% of the
parasites as belonging to Viannia (61/65) and 6.2% to Leishmania
(4/65) complexes.
When the results comparing both methods of isolation per-
formed at the same time are considered (Table 2), in agreement
with the data from Table 1, we ﬁnd that ex vivo isolation was more
efﬁcient for the isolation of CL parasites, and in vivo isolation was
more efﬁcient for the isolation of ML parasites (CL: 33.8% vs.
18.9%, p = 0.06; ML: 12.0% vs. 24.0%). Of the eight ML isolates, ﬁve
were obtained only after inoculation in mice (Table 2). All of the
ML isolates from both isolation methods were cryopreserved, as
Table 1
Overall rates of detection/isolation of New World Leishmania sp using ex vivo cultures or IFNc KO micea.
Disease Samples Isolations/cultures Isolations/mice eTotal of isolations fTotal of isolates cryopreserved gContaminations/cultures
bCL 86 29/85#(34.1%)* 14/75§(18.7%) 35/86(40.2%) 27/35(77.1%) 15/85#(17.6%)
cML 28 3/27#(11.1%) 6/25§(24.0%) 8/28(29.6%) 8/8(100%) 8/27#(29.6%)
dATL 114 32/112 (28.6%) 20/100(20.0%) 43/114 (37.8%) 35/43(81.4%) 23/112#(20.5%)
a All samples processed for ex vivo or in vivo isolation are showed independent on they were processed simultaneously for both methods or not.
b CL (Cutaneous leishmaniasis): LCL, DCL, DfCL .
c ML (Mucosal leishmaniasis): MCL, ML.
d ATL (American tegumentary leishmaniasis): CL; ML.
e Total of isolations considering that some parasites were simultaneously isolated in culture and in mice. Isolation is deﬁned as positive culture with or without
cryopreservation of the parasites.
f Isolates are deﬁned as parasites that were cryopreserved with success.
g Data represent contaminations during the culture of the patient biopsy fragments.
* P < 0.05 (CL: culture vs mice, Fisher’s test).
# One CL sample and one ML sample were not prepared for ex vivo but only for in vivo isolation.
§ Eleven CL samples and three ML were not inoculated into mice.
Table 2
Comparison between ex vivo cultures and IFNc KO mice as methods to isolate and stock New World Leishmania spa.
Disease Samples eIsolations/
cultures
fIsolations/
mice
gIsolations/cultures
and mice
hTotal isolations/
cultures
iTotal isolations/
mice
Total of
isolations
Total of isolates
cryopreserved
bCL 74 16(21.6%)⁄ 5(6.7%) 9(12.2%) 25(33.8%)# 14(18.9%) 30(40.5%) j22/30(73.3%)
cML 25 2(8.0%) 5(20.0%) 1(4.0%) 3(12.0%) 6(24.0%) 8(32.0%) 8/8(100%)
dATL 99 18(18.2%) 10(10%) 10(10%) 28(28.3%) 20(20.2%) 38(38.4%) 30/38(78.9%)
a All samples were processed for ex vivo or in vivo isolation simultaneously.
b CL (Cutaneous leishmaniasis): LCL, DCL, DfCL.
c ML (Mucosal leishmaniasis): MCL, ML.
d ATL (American tegumentary leishmaniasis): CL; ML.
e Total of isolations only in cultures.
f Total of isolations only in mice.
g Total of isolations simultaneously in culture and in mice.
h Total of isolations in culture (culture + culture and mice).
i Total of isolations in mice (mice + culture and mice).
j Eight cultures were positive (mice: negative) but parasites stopped to growth (n = 6) or there was further contamination of fragment biopsy cultures (n = 2). Thus, for CL
there were 17 cryopreserved isolates from culture isolations (eight only culture + nine in culture and mice) in 25 isolations in culture (68.0%). All isolates obtained from
mice were cryopreserved.
* P < 0.05 and.
# P = 0.06 (CL: culture vs mice, Fisher’s test).
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CL parasites obtained from cultures were stocked (Table 2). Of the
eight CL positive cultures, parasites were not stocked due to con-
tamination (n = 2) or because the parasites had stopped growing
(n = 6, Table 2).4. Discussion
Biopsy culture has been used for ATL diagnosis with parasite
isolation rates varying from 35.8 to 49.4% using biphasic agar-li-
quid media (Weigle et al., 1987; Passos et al., 1999). Our results
are similar to these overall rates of parasite isolation. Passos
et al. (1999) reported that only 63.0% of the parasites were stocked
for further experiments, a rate lower than was obtained in the
present study. In some reports, aspirate cultures instead of biopsy
cultures were used to isolate parasites from ATL patients with a
success rate around 40–50% using different culture media (Weigle
et al., 1987; Romero et al., 2001; Mimori et al., 2002). In these stud-
ies, the number of ML patients was very low, and the success of
storing the parasite isolates for further studies was not reported.
In the present study, we found that ex vivo isolation was an efﬁ-
cient method for CL parasite isolation, whereas the in vivo isolation
method improved the isolation of parasites from ML patients. In
fact, ﬁve of the eight ML isolates were obtained only in mice, indi-
cating that the use of IFNc KO mice improves the isolation of par-
asites from ML lesions. The contamination rate of patient biopsyfragment cultures was higher for CL cultures than ML lesion cul-
tures. However, the cultures of the mouse lesions were less prone
to contamination, and no culture contamination occurred regard-
less of whether they were injected with CL or ML lesion fragments.
In our experiments, all ML isolates obtained from mice or cul-
tures as well as all isolates obtained from mice (CL and ML) were
successfully cultured and could be stocked. Of the eight CL parasite
isolations from ex vivo cultures, six were not stocked due to further
growth failure. The reason that some parasites stop growing
in vitro after an initial growth increase is unknown, but it could
be because the parasite failed to adapt to the culture conditions. In-
deed, the adaptation of recently isolated parasites is quite variable,
and we suggest that some parasites may have more stringent
requirements for the culture medium composition. Different
batches of FCS can interfere with the growth of parasites, and
although we tested all the FCS batches, small batch-to-batch vari-
ations were always observed. Another possibility for the growth
failure is that the number of parasites obtained from some
ex vivo cultures did not reach the density necessary for growth,
but when the parasites are ﬁrst expanded in vivo in IFNc KO mice,
they were all successfully cultured. The idea that the parasites
need an optimal density to proliferate is supported by the observa-
tion that the in vitro passages of some isolates must start at least
with 106 parasites/ml.
Another potential contribution of the IFNc KO mice to the im-
proved isolation rate could be an in vivo selection process that re-
sults in parasites that grow better in cultures. The advantage of the
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be related to its capacity to circumvent the contaminations due to
nasal or oral ﬂora, and to allow for the isolation of parasites from
samples with low numbers of parasites. Although the IFNc KO
mouse is not recommended for the diagnosis of ATL because isolat-
ing parasites from the mice is time consuming (Oliveira et al.,
2010), and the maintenance of animal facilities is expensive, this
model is valuable for the isolation of parasites from ML patients.
Additionally, IFNc KO mice have been used to help us to recover
parasites that do not grow well after thawing and to maintain par-
asite virulence. Our experience in isolating Leishmania from pa-
tients has proven the isolation to be a meticulous process in
which success depends on several variables, including parasite
species, culture and animal conditions, and technical competence.
Nevertheless, it is very important to stock parasites for genetic
diversity studies as well as host–parasite interactions to detect bio-
logical markers of NewWorld Leishmania. In conclusion, the ex vivo
culture of lesion fragments is adequate for the isolation of parasites
from cutaneous lesions, but the use of IFNc KO mice is recom-
mended as an additional method for the isolation of parasites from
mucosal lesions.
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